ARCH — Arch Biopartners Cashflow Statement
0.000.00%
Last trade - 00:00- CA$54.22m
- CA$57.05m
- CA$0.28m
Annual cashflow statement for Arch Biopartners, fiscal year end - September 30th, CAD millions except per share, conversion factor applied.
2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | 2025 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash from Operating Activities | -2.98 | 0.479 | -0.234 | -2.33 | -1.58 |
| Financing Cash Flow Items | — | — | — | — | 0.675 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.78 | -0.421 | 0.559 | 1.5 | 1.58 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.205 | 0.058 | 0.325 | -0.828 | -0.001 |